FIELD: organic chemistry, chemical technology, pharmacy. SUBSTANCE: invention describes the novel oligosaccharide-containing 14-aminosteroids of the general formula (I) where R1 means COO-R5 where R5 is lower alkyl with 1-6 carbon atoms, COR where R is amino-group possibly substituted with lower alkyl with 1-6 carbon atoms; R2 is NH2-group; R3 is oligosaccharide residue of the formula (II) where Rg means hydrogen atom, hydroxy-, acetoxy-, benzoylhydroxy-group; R10 means oxygen atom and if further R11 is a substituent of terminal monosaccharide residue then R11 means OH, methyl, acetoxy-group and R12 means hydrogen atom, methyl, methylhydroxymethyl or oligosaccharide residue of the general formula (III) where R14 and R15 are similar or different and mean lower alkyl with 1-6 carbon atoms; R17/ can be hydrogen atom, hydroxy-, acetoxy- or benzoxy-group; R18 and R19 means hydroxy-, acetoxy- or benzoxy-group or oligo-saccharide residue of the general formula (IV) where R14 and R15 are similar or different and mean lower alkyl with 1-6 carbon atoms; R14a means hydroxy-, acetoxy-group; R4 means H. Compounds of the formula (I) show activity in treatment of patients with congestive heart failure since they enhance contractive capability of heart muscle. Invention describes also method of their synthesis, pharmaceutical composition based on compounds of the formula (I), method of patient treatment and method of incorporation of amino-group. EFFECT: new compounds indicated above, improved method of synthesis, valuable pharmacological properties. 12 cl, 7 ex
Title |
Year |
Author |
Number |
NEUROACTIVE STEROIDS, PHARMACEUTICAL PREPARATION, METHOD OF TREATMENT AND PROPHYLAXIS OF DIFFERENT DISORDERS, METHOD OF SLEEP INDUCTION AND METHOD OF ANESTHESIA INDUCTION WITH THEIR USING, METHOD OF MODULATION OF COMPLEX RECEPTOR GABAA-CHLORIDE IONOPHORE |
1996 |
- Lehn Nensi K.
- Fik Dehvid B.
- Khogenkehmr Derk Dzh.
- Jupehzehnaj Rehjvindra B.
|
RU2194712C2 |
DERIVATIVES OF 5-HYDRAZINOQUINOLONE, COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF INFECTION DISEASE, METHOD OF TREATMENT AND PROPHYLAXIS |
1993 |
- Demut Tomas Prosser
- Uajt Ronal'D Judzhin
|
RU2126000C1 |
METHOD OF PREPARING QUINOLINYL LACTAMS OR SALTS THEREOF |
1992 |
- Ronal'D Jugen Uajt
- Tomas Prosser Demut, Ml.
|
RU2130938C1 |
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE |
1992 |
- Glenn Dzh.Gomlej
- Ehlizabet Stoner
|
RU2125879C1 |
PHOSPHINIC ACID AMIDES AND METHOD OF PROPHYLAXIS OR TREATMENT OF PATIENTS ASSOCIATED WITH UNFAVORABLE METALLOPROTEASE ACTIVITY |
1997 |
- Pikul Stanislav
- Makdau-Dankhehm Kelli Linn
- De Bisvanatkh
- Tajvo Ietunde Olabisi
|
RU2170232C2 |
METHOD FOR PREPARING INTERMEDIATE SUBSTANCES FOR QUINOLONE ANTIBIOTICS |
2003 |
|
RU2289576C2 |
SECONDARY (2,3) ALKYL SULFATE SURFACTANTS IN MIXED SURFACTANT PARTICLES |
1994 |
- Murch Brjus Prentiss
- Morrall Stiven Vil'Jam
|
RU2127301C1 |
DERIVATIVES OF DIHYDROBENZOPYRANE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF TREATMENT |
1997 |
- Janush Dzhon Majkl
- Dzhonson Karl Randol'F
- Senanajake Chandravansha Bandara V.
|
RU2156762C1 |
METHOD OF PRODUCING 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS |
2008 |
- Khehzel'Khoff Klaus-Kristian
- Petersen Majk
|
RU2466137C2 |
DERIVATIVES OF ANDROSTANE SUBSTITUTED AT 16-POSITION WITH QUATERNARY AMMONIUM GROUP, PHARMACEUTICAL COMPOSITION |
1993 |
- Zoltan Tuba
- Sil'Vester E.Vizi
- Ferents F.Foldes
- Shandor Makho
|
RU2124021C1 |